The KDEL receptor 2 (KDELR2) is an integral membrane protein that plays a critical role in the retrieval of escaped endoplasmic reticulum (ER) resident proteins from the Golgi apparatus back to the ER, maintaining ER homeostasis and proper protein folding. This receptor recognizes proteins that have erroneously exited the ER, which typically contain a specific KDEL sequence (Lys-Asp-Glu-Leu) at their C-terminus, binding them and ensuring their retrograde transport. The functioning of KDELR2 is pivotal in the protein quality control system within the cell, helping to prevent the accumulation of misfolded proteins that could lead to cellular stress and disease. By efficiently recycling ER proteins, KDELR2 supports the ER's capacity to manage protein synthesis, folding, modification, and trafficking, processes essential for cell survival and function.
The inhibition of KDELR2 could disrupt the delicate balance of protein trafficking between the ER and Golgi apparatus, leading to an accumulation of ER-resident proteins in the Golgi, potentially triggering ER stress and the unfolded protein response (UPR). Mechanisms of inhibition could involve the direct binding of inhibitors to the receptor, preventing its interaction with KDEL-containing cargo proteins, or the alteration of the receptor's ability to cycle between the Golgi and ER. Additionally, inhibition could occur through the modulation of the cellular signaling pathways that regulate KDELR2 expression or function, such as those involved in the UPR, cellular stress responses, or vesicular trafficking pathways. Since KDELR2 is involved in essential cellular processes, its inhibition must be approached with caution, as it could have widespread effects on cell viability, protein homeostasis, and the overall functioning of the secretory pathway. Understanding the precise mechanisms through which KDELR2 operates and can be inhibited provides valuable insights into the regulation of protein trafficking and the maintenance of cellular homeostasis, highlighting the complex interplay between various cellular organelles and processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts ER-Golgi transport, affecting the KDELR2 recycling mechanism. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Ionophore that disrupts Golgi function, potentially impeding KDELR2-mediated retrieval. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Inhibits N-linked glycosylation, indirectly affecting KDELR2's glycoprotein clients. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
ER stress inducer that can lead to KDELR2 dysregulation by overwhelming ER functions. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Inhibits glycoprotein processing, possibly impacting KDELR2's client handling. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $138.00 $251.00 $631.00 $815.00 $1832.00 | 6 | |
Inhibits glycoprotein processing in ER and Golgi, affecting KDELR2's function indirectly. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Inhibitor of N-linked glycosylation, potentially affecting KDELR2 substrate specificity. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Selective inhibitor of eIF2α dephosphorylation, can lead to ER stress affecting KDELR2. | ||||||
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $102.00 $468.00 $832.00 $4162.00 $7283.00 | 2 | |
Alters eIF2α phosphorylation, indirectly influencing KDELR2 through ER stress pathways. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that can lead to ER stress, indirectly affecting KDELR2. | ||||||